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Abstract 
The 6th Pan Arab Human Genetics Conference (PAHGC), “Genetics of Multifactorial Disorders” was organized by the 
Center for Arab Genomic Studies (http://www.cags.org.ae) in Dubai, United Arab Emirates from 21 to 23 January, 2016. 
The PAHGCs are held biennially to provide a common platform to bring together regional and international geneti‑
cists to share their knowledge and to discuss common issues. Over 800 delegates attended the first 2 days of the 
conference and these came from various medical and scientific backgrounds. They consisted of geneticists, molecular 
biologists, medical practitioners, postdoctoral researchers, technical staff (e.g., nurses and lab technicians) and medi‑
cal students from 35 countries around the world. On the 3rd day, a one‑day workshop on “Genetic Counseling” was 
delivered to 26 participants. The conference focused on four major topics, namely, diabetes, genetics of neurodevel‑
opmental disorders, congenital anomalies and cancer genetics. Personalized medicine was a recurrent theme in most 
of the research presented at the conference, as was the application of novel molecular findings in clinical settings. This 
report discusses a summary of the presentations from the meeting.
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Background
The 6th Pan Arab Human Genetics Conference, “Genet-
ics of Multifactorial Disorders” was hosted by Sheikh 
Hamdan Bin Rashid Al Maktoum Award for Medical 
Sciences (http://hmaward.org.ae) and organized by the 
Center for Arab Genomic Studies (http://www.cags.org.
ae) in Dubai, United Arab Emirates from 21 to 23 Janu-
ary, 2016. The event consisted of a 2  day conference as 
well as a 1  day workshop on “Genetic Counseling”. The 
opening ceremony was headed by H.E. Humaid Al 
Qatami, Chairman of the Board and Director-General of 
the Dubai Health Authority, and was attended by mem-
bers of the Board of Trustees of the Sheikh Hamdan 
Award for Medical Sciences.
The 2-day conference featured 113 research papers that 
were the basis for seven keynote lectures, 12 oral pres-
entations and 94 posters. The number of contributors to 
these research papers reached 426 researchers from 35 
countries including USA, UK, Germany, Canada, Aus-
tralia, United Arab Emirates, and Saudi Arabia. These 
research papers revolved around four main topics: diabe-
tes and other metabolic disorders, genetics of neurode-
velopmental disorders, congenital anomalies and cancer 
genetics. Using modern advances in high throughput 
sequencing techniques was at the center of many 
research papers, especially in the context of providing 
personalized clinical care to patients.
In addition, an exhibition was held on the sidelines 
of the conference, where seven commercial companies 
showcased the latest technologies and services offered by 
them for human genomics and proteomics that are read-
ily applicable for personalized medicine.
Session 1
In his keynote lecture, Prof. Mark McCarthy from the 
Oxford Centre for Diabetes provided an overview of 
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understanding of Type 2 diabetes mellitus (T2DM) and 
helping drug discovery achieve better and faster yields 
[1]. Of the 100 common variants identified by GWAS to 
be associated with T2DM, techniques such as functional 
enrichment and using positional candidates have resulted 
in the discovery of close to 33 functional candidate genes, 
which can serve as putative therapeutic targets.
The Centre for Arab Genomic Studies (CAGS) show-
cased its new line of research using the tools of meta-
analysis to increase statistical power of studies conducted 
on Arab populations. “Type I diabetes (T1D) and HLA 
class II alleles in Arabs” was the focus of the first series of 
meta-analyses conducted by the Centre. Dr. Abdul Rez-
zak Hamzeh explained the main findings of these studies 
and pinpointed the place of Arab data on the global map 
of ethnic-specific data in the context of T1D [2, 3].
Dr. Anette Gjesing presented some of the work done 
at the University of Copenhagen in studying the preva-
lence of Maturity Onset Diabetes of the Young (MODY) 
variants in Danish women with a history of gestational 
diabetes (GDM). This study is similar to an earlier study 
done by the team on the Czech population [4]. The 
study found that 11  % of diabetes among women with 
a history of GDM could be explained by MODY vari-
ants. These women were also found to be three times 
more likely to develop diabetes 10-years later. Diagno-
sis of MODY relies majorly on genetic testing, which is 
expensive. Dr. Hinda Daggag delivered a talk about her 
work at the Imperial College of London Diabetes Cen-
tre, which involves using Urinary C-Peptide Creatinine 
Ratio (UCPCR) to diagnose MODY [5]. Her experience 
with UCPCR testing in the Emirati population seems to 
suggest that cut-off limits for MODY in this population 
are lower than the UK limits among pediatric cases and 
higher among adult cases.
The evolutionary origin of obesity has attracted much 
popular attention in recent years. Dr. Vadim Stepanov 
presented the results of his work at the Research Insti-
tute for Medical Genetics in Tomsk where his group tried 
to use genome wide association studies to understand 
whether obesity is a decanalized phenotype. Their results 
indicate that observed worldwide frequency spectrum 
in obesity-associated genes may be, at least partially, 
explained by the hypothesis of canalization/decanaliza-
tion of genotype-environment relationships under the 
pressure of natural selection driven by adaptation to new 
environment during human migrations.
Session 2
Prof. Alain Verloes’ keynote lecture on the session on 
‘Genetics of Neurodevelopmental Disorders’ was a 
detailed look into primary microcephalies and how 
recent genetic discoveries have, to a large extent, blurred 
the classification of this heterogenous group of disorders 
[6]. At the beginning of the century, the clinical picture of 
primary microcephalies was straight forward and simple, 
with six distinct entities. However, the current pathoge-
netic classification is a clinical puzzle, with continuum 
between typical and atypical cases, extensive overlap 
between clinical diagnoses, and wide genetic heterogene-
ity. Difficult as it may be, identifying the genetic cause of 
microcephalies is important because there are prognos-
tic implications for the neurodevelopmental outcome. 
Equally important is the delineation of the pathogenetic 
mechanism underlying the condition. Dr. Ganeshwaran 
Mochida described his work on using CRISPR-Cas9 
technology to create a cellular model of microcephaly. 
His team worked on two different mutations in the ASNS 
gene leading to a microcephalic syndrome in two unre-
lated Arab families. By creating ASNS deficient cell-lines 
using CRISPR-Cas9 genome editing, they were able to 
show reduced proliferation and increased apoptosis, 
which was alleviated by asparagine supplementation. Dr. 
Irma Jarvela presented another case study of a consan-
guineous Finnish family with non-syndromic intellectual 
disability, in which whole exome sequencing identified a 
novel missense variant in the C12orf4 gene. Among local 
blood donors, this variant was found with a carrier fre-
quency of 1:53, indicating a founder effect and a possible 
enrichment in this population. Dr. Mohammed Ansari 
described protein-docking experiments conducted by his 
group and aimed at understanding the polymerization of 
alpha-synuclein (SNCA) in synucleopathies. This study 
enabled the identification of key residues involved in the 
interaction of the oligomerization assembly, and has the 
potential to guide therapeutic strategies towards major 
neurodegenerative disorders involving synucleopathies.
Session 3
Prof. Stylianos Antonarakis, the current President of the 
Human Genome Organization delivered the keynote lec-
ture in the session on congenital disorders. He provided a 
detailed history of personalized medicine and his visuali-
zation of genomic medicine for the future. He introduced 
the ‘genome clinic’, developed in the University Hospi-
tals of Geneva to offer genome diagnostics of Mendelian 
and complex genetic disorders, for the identification of 
somatic driver variants in cancer, and to educate the pop-
ulation on risk perceptions and acceptance of genomic 
medicine. The results from the clinic show a 40 % success 
rate in identifying the pathogenic variant, with most suc-
cess coming from Mendelian disorders other than those 
leading to developmental delay and intellectual disabil-
ity. The role of sequencing in congenital disorders was 
exemplified by two lectures, both from the King Faisal 
Specialist Hospital and Research centre in Saudi Arabia. 
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Prof. Al-Owain described the delineation of a novel syn-
drome of congenital cataract and abnormal striatum in 
a consanguineous family, which was found after exome 
sequencing studies to be linked to KCNA4 mutations. 
Similarly, Dr. Salma Majid used homozygosity mapping 
and exome sequencing to identify a novel locus (LACC1) 
with systemic Juvenile Idiopathic Arthritis [7]. Dr. Tawfeg 
Ben-Omran from Hamad Medical Corporation in Qatar 
presented the results of his study on the relation between 
consanguinity and genetic disorders in the country, 
which suggests a significant role of paternal consanguin-
ity in the increase in prevalence of genetic conditions, 
especially autosomal recessive disorders.
Session 4
Sir John Burn highlighted various important aspects of 
translational research in genomic medicine. The first of 
these was exemplified by the ‘BRCA Challenge’project, 
which aims to pool together, genetic variations and 
respective phenotypes of BRCA1 and BRCA2 [8]. He 
also presented the results of the Cancer Prevention Pro-
ject (CAPP), which aims to test the efficacy of Aspirin as 
a chemopreventive agent for colorectal cancer. Finally, 
as an update to developments in diagnostics, the ‘hand-
held laboratory’ Q-POC was introduced. This device uses 
nanowire technology to detect DNA sequence variation 
through changes in electrical current upon binding of 
sample DNA. The use of disposable cassettes facilitates 
the analysis of DNA on the spot, in less than 20 min, with 
low cost and low energy consumption. This device was 
demonstrated to be an efficient replacement to conven-
tional methods in multiple aspects, such as identifying 
tumor markers, determining genotype-guided doses of 
medicine such as Warfarin, or determining drug resist-
ance to Tuberculosis. Prof. Shama Prasada spoke in detail 
on the use of epigenetically modified genes as diagnos-
tic markers in cancer; as an example, he illustrated how 
different levels of aberrant methylation in multiple genes 
correlates with different stages of cervical cancer. In 
addition, he shared his recently published results on the 
tumor suppressor function of a previously untested gene, 
Double C2-like Domain β (DOC2B), which encodes a 
calcium sensor involved in neurotransmitter release and 
exocytosis. Due to the hypermethylated state and low 
expression of DOC2B in the pre-malignant stage of cervi-
cal cancer, it may potentially be used as a reliable marker 
for early diagnosis [9, 10]. Dr. Abeer Alsaegh addressed 
various challenges faced in the implementation of a can-
cer genetics service in Oman, offered by Sultan Qaboos 
University Hospital. She spoke on the recent efforts to 
organize the details of patients referred for cancer ser-
vices through the construction of a database, and shared 
statistical data of mutations in specific genes for breast 
and colon cancers. She highlighted the high consanguin-
ity rate in Oman, and the extremely high rate in those 
who are referred for familial cancer testing. She described 
the significant reluctance of Omani individuals and fami-
lies in participating in genetic counselling and testing, 
which should be addressed through raising awareness 
and promoting education in the general public.
The genetic counselling workshop
On the third day, a specialist workshop was delivered by 
Dr. Christine Patch from Guy’s Hospital, London and Dr. 
Anna Middleton, from Wellcome Trust Sanger Institute. 
The workshop introduced the basic principles of genetic 
counseling and explored different ethical issues in coun-
selling using role plays and real-life case studies. Some of 
these case studies discussed issues such as genetic coun-
seling for developmental disorders, disability, prenatal 
genetic diagnosis, and pre-symptomatic testing.
Conclusions
Pan Arab Human Genetics Conferences (PAHGC) are 
held biennially to provide a common platform to bring 
together regional and international geneticists to share 
their knowledge and to discuss common issues, and the 
sixth version of this series was no exception. As well as 
offering a great opportunity for young and more experi-
enced scientists to mingle, the 6th PAHGC contributed 
significantly to the advancement of human genetics and 
its applications in general. As a matter of fact, the event 
focused on the most pressing issue of our time, person-
alized medicine. Obviously, the hottest topic in human 
genetics is the great speed at which molecular analyses 
can be performed these days, and researchers all over the 
world are trying to “translate” these advancements into 
optimal treatment for patients. This issue featured repeat-
edly throughout the conference and many brilliant ideas 
were exchanged in this regard. The organizers also wished 
to shed light on the challenges faced by the medical sec-
tor upon trying to deliver this wealth of information to the 
general public, and hence the chosen topic of the work-
shop was “genetic counselling”. In fact, there is a dire need 
for more qualified genetic counsellors in this part of the 
world and efforts such as the conference and its workshop 
are mere steps towards addressing this problem.
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